Role of Cannabinoids in Pain Management
Authors:
- Omar I. HalawaOHOmar I. Halawa
- Timothy J. FurnishTFTimothy J. Furnish
- Mark S. WallaceMWMark S. Wallace
- 23 March 2018
- book chapter
- Published by Elsevier
- p. 509-520.e2
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Persistent cannabis users show neuropsychological decline from childhood to midlifeProceedings of the National Academy of Sciences of the United States of America, 2012
- Cannabinoids for treatment of chronic non‐cancer pain; a systematic review of randomized trialsBritish Journal of Clinical Pharmacology, 2011
- Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: Results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)Drug and Alcohol Dependence, 2011
- Antidepressant-like effect of Δ9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.Pharmacology Biochemistry and Behavior, 2010
- Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical TrialNeuropsychopharmacology, 2008
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarinBritish Journal of Pharmacology, 2008
- The orphan receptor GPR55 is a novel cannabinoid receptorBritish Journal of Pharmacology, 2007
- The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effectsBritish Journal of Pharmacology, 2007
- Effects of Marijuana Smoking on Pulmonary Function and Respiratory ComplicationsArchives of internal medicine (1960), 2007
- The Endocannabinoid System as an Emerging Target of PharmacotherapyPharmacological Reviews, 2006